Stryjewski M.E. Chu V.H. O'Riordan W.D. Warren B.L. Dunbar L.M. Young D.M. Vallee M. Fowler Jr. V.G. Morganroth J. Barriere S.L. Kitt M.M. Corey G.R.
(2006)
Telavancin is a bactericidal lipoglycopeptide with a multifunctional mechanism of action. We conducted a randomized, double blind, active-control phase II trial. Patients S18 years of age with complicated skin and skin ...